Related Experiment Videos
A new nomogram to predict pathologic outcome following radical prostatectomy.
Alexandre Crippa1, Miguel Srougi, Marcos F Dall'Oglio
1Division of Urology, Federal University of Sao Paulo, UNIFESP, Sao Paulo, SP, Brazil. drcrippa@uol.com.br
Summary
A new nomogram accurately predicts extraprostatic disease extension in localized prostate cancer patients. It incorporates serum PSA, biopsy Gleason score, and positive biopsy core percentage for better preoperative risk assessment.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Localized prostate cancer requires accurate preoperative staging.
- Predicting extraprostatic extension is crucial for treatment planning.
Purpose of the Study:
- To develop a preoperative nomogram for predicting pathologic outcomes in patients undergoing radical prostatectomy for localized prostate cancer.
- To assess the predictive accuracy of incorporating serum PSA, biopsy Gleason score, and percentage of positive biopsy cores.
Main Methods:
- Multivariate analysis of 898 patients with clinical stage T1-T2 prostate cancer.
- Development of two nomograms incorporating serum PSA, biopsy Gleason score, and positive biopsy core percentage.
- Validation of nomogram predictive accuracy.
Main Results:
- Serum PSA, biopsy Gleason score, and positive biopsy cores were significant predictors of extraprostatic tumor extension.
- Nomogram-1 and Nomogram-2 demonstrated high accuracy (87% and 91.1%) in predicting pathological stage.
- Gleason score grouping influenced predictive performance.
Conclusions:
- A nomogram combining serum PSA, biopsy Gleason score, and positive biopsy core percentage accurately predicts extraprostatic disease extension.
- This tool aids in preoperative risk stratification for localized prostate cancer.
- The nomogram can improve surgical planning and patient counseling.